Earlier, the Audit Committee of CMO had informed the SEC of the issues raised by the auditor from the audit of the company’s financial statements as follows: an irregular withdrawal of advance

/LawandRegulations/ShareWarrant.aspx English (United States) IndependentAuditOversight found in various jurisdictions raised serious concerns among capital market regulators on the quality of financial statements and

must disclose the minimum requirements in a format and within the https://www.sec.or.th/EN/Pages/LawandRegulations/ShareWarrant.aspx English (United States) IndependentAuditOversight found in various

Pursuant to Mr. Akeyuth Anchanbutr?s statement through various media concerning irregular trading of SCIB-C1 during August 11-16, 2004 and his request for the SEC to pursue further investigation in

transaction is an appropriate and beneficial to the Company on a long- term basis, and no disagreement to the Company’s Board of Directors has been raised by the Company’s directors and/or the audit committee

interest in AI technology. Additionally, sales have been boosted by various accessory products. The company continues to focus on a strategy of selling accessories alongside primary products, which helps

PLE during the said periods raised the issue of unfairness to the PLE financial position and the performance of the PLE group. The deadline for submitting the corrected financial statements is

.  __________________________Remark:* SEC News No. 195/2023 headlined: SEC instructs CMO to arrange a special audit on issues raised by the auditor, issued on 24 October 2023. https://www.sec.or.th/EN/Pages/News_Detail.aspx?SECID

or 22.90% over the same period of last year of which hospital revenues totally raised by 10.16% along with the enlarged customer base of Subsidiary (AMARC) showing 15.67% of revenues’ growth. In